Form 4: Winmark Corp Director Philip Irving Smith Acquires Stock Options
SEC Form 4 Filing
Director Philip Irving Smith acquired non-employee stock options in Winmark Corp on June 1, 2024.
Summary
- Philip Irving Smith, a director of Winmark Corp, reported changes in beneficial ownership to the SEC.
- On June 1, 2024, Smith acquired 300 non-employee stock options with an exercise price of $355.90, exercisable 25% per year for four years starting June 1, 2025, and expiring on June 1, 2034.
- Smith also holds other non-employee stock options: 4,500 options with an exercise price of $291.01, 380 options with an exercise price of $325.99, and 240 options with an exercise price of $446.68.
- The reported transaction was filed on June 3, 2024.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The acquisition of stock options by a director is generally viewed as a positive sign, but the document itself is simply a regulatory filing.
Positives
- The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Stock option grants to directors are a common practice in corporate governance, aligning their interests with those of shareholders.
Comparison to Industry Standards
- Stock option grants are a typical component of executive compensation packages across various industries.
- The vesting schedule of 25% per year over four years is a fairly standard vesting arrangement.
- Comparing the exercise prices to the current market price of WINA would provide further context on the potential value of these options.
Stakeholder Impact
- The acquisition of stock options by a director could positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/01/2024 | Date of existing non-employee stock options with exercise price of $291.01 |
| 06/01/2024 | Date of transaction: Acquisition of 300 non-employee stock options at $355.90. |
| 12/11/2024 | Date of existing non-employee stock options with exercise price of $446.68 |
| 06/01/2025 | First vesting date (25%) for the 300 options acquired on June 1, 2024. |
| 03/01/2033 | Expiration date of existing non-employee stock options with exercise price of $291.01 |
| 06/01/2033 | Expiration date of existing non-employee stock options with exercise price of $325.99 |
| 12/11/2033 | Expiration date of existing non-employee stock options with exercise price of $446.68 |
| 06/01/2034 | Expiration date for the 300 options acquired on June 1, 2024. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.